Differential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy

[1]  Pham Nguyen Quy,et al.  Proteasome-dependent Activation of Mammalian Target of Rapamycin Complex 1 (mTORC1) Is Essential for Autophagy Suppression and Muscle Remodeling Following Denervation* , 2012, The Journal of Biological Chemistry.

[2]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[3]  Dudley Lamming,et al.  Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity , 2012, Science.

[4]  P. Puigserver,et al.  Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function , 2011, Proceedings of the National Academy of Sciences.

[5]  M. Hall,et al.  mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. , 2011, The Journal of clinical investigation.

[6]  R. Wanke,et al.  Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. , 2011, The Journal of clinical investigation.

[7]  M. Hall,et al.  Cardiac Raptor Ablation Impairs Adaptive Hypertrophy, Alters Metabolic Gene Expression, and Causes Heart Failure in Mice , 2011, Circulation.

[8]  D. Gutmann,et al.  Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. , 2011, Human molecular genetics.

[9]  D. Glass,et al.  Molecular mechanisms and treatment options for muscle wasting diseases. , 2011, Annual review of pharmacology and toxicology.

[10]  D. Gutmann,et al.  Tsc 2 gene inactivation causes a more severe epilepsy phenotype than Tsc 1 inactivation in a mouse model of Tuberous Sclerosis Complex , 2011 .

[11]  C. Zechner,et al.  Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. , 2010, Cell metabolism.

[12]  T. Hornberger,et al.  A PI3K/PKB-Independent Activation of mTOR Signaling is Sufficient to Induce Skeletal Muscle Hypertrophy , 2010 .

[13]  T. Hornberger,et al.  A Phosphatidylinositol 3-Kinase/Protein Kinase B-independent Activation of Mammalian Target of Rapamycin Signaling Is Sufficient to Induce Skeletal Muscle Hypertrophy , 2010, Molecular biology of the cell.

[14]  A. Goldberg,et al.  Peroxisome Proliferator-activated Receptor γ Coactivator 1α or 1β Overexpression Inhibits Muscle Protein Degradation, Induction of Ubiquitin Ligases, and Disuse Atrophy* , 2010, The Journal of Biological Chemistry.

[15]  G. Cossu,et al.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. , 2010, The Journal of clinical investigation.

[16]  L. Schaeffer,et al.  Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy , 2009, The Journal of cell biology.

[17]  H. Münzberg,et al.  Critical roles for the TSC-mTOR pathway in β-cell function. , 2009, American journal of physiology. Endocrinology and metabolism.

[18]  H. Münzberg,et al.  Critical role for hypothalamic mTOR activity in energy balance. , 2009, Cell metabolism.

[19]  A. Akatsuka,et al.  Multiple stimulations for muscle–nerve–blood vessel unit in compensatory hypertrophied skeletal muscle of rat surgical ablation model , 2009, Histochemistry and Cell Biology.

[20]  Philippe Pierre,et al.  SUnSET, a nonradioactive method to monitor protein synthesis , 2009, Nature Methods.

[21]  E. Casanova,et al.  Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. , 2008, Cell metabolism.

[22]  J. Auwerx,et al.  Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. , 2008, Cell metabolism.

[23]  Marco Sandri,et al.  Signaling in muscle atrophy and hypertrophy. , 2008, Physiology.

[24]  B. Manning,et al.  The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2 , 2008, Molecular and Cellular Biology.

[25]  N. LeBrasseur,et al.  Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. , 2008, Cell metabolism.

[26]  A. Goldberg,et al.  FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.

[27]  A. Goldberg,et al.  FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.

[28]  V. Mootha,et al.  mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex , 2007, Nature.

[29]  John C. Lawrence,et al.  Muscle-Specific Deletion of Rictor Impairs Insulin-Stimulated Glucose Transport and Enhances Basal Glycogen Synthase Activity , 2007, Molecular and Cellular Biology.

[30]  F. Jensen,et al.  A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival , 2007, The Journal of Neuroscience.

[31]  Donglei Zhang,et al.  Expression pattern of myostatin in gastrocnemius muscle of rats after sciatic nerve crush injury , 2007, Muscle & nerve.

[32]  S. Bodine,et al.  Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. , 2007, Journal of applied physiology.

[33]  B. Spiegelman,et al.  The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. , 2007, Cell metabolism.

[34]  Barbara Cannon,et al.  Ablation of PGC-1β Results in Defective Mitochondrial Activity, Thermogenesis, Hepatic Function, and Cardiac Performance , 2006, PLoS biology.

[35]  Jiandie D. Lin,et al.  PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.

[36]  Min Han,et al.  Muscle atrophy in transgenic mice expressing a human TSC1 transgene , 2006, FEBS letters.

[37]  K. Inoki,et al.  TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[39]  N. Sonenberg,et al.  Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control , 2005, Nature Cell Biology.

[40]  T. Shavlakadze,et al.  Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy , 2005, Neuromuscular Disorders.

[41]  G. Yancopoulos,et al.  Conditional Activation of Akt in Adult Skeletal Muscle Induces Rapid Hypertrophy , 2004, Molecular and Cellular Biology.

[42]  R. Loewith,et al.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.

[43]  A. Briguet,et al.  Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse , 2004, Neuromuscular Disorders.

[44]  D. Guertin,et al.  Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.

[45]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.

[46]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[47]  P. Barzaghi,et al.  Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference , 2004, EMBO reports.

[48]  E. Wolf,et al.  Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic mdx mice. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[49]  U. Müller,et al.  Beta1 integrins regulate myoblast fusion and sarcomere assembly. , 2003, Developmental cell.

[50]  P. Puigserver,et al.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. , 2003, Endocrine reviews.

[51]  Jiandie D. Lin,et al.  Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres , 2002, Nature.

[52]  E. Calabria,et al.  A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Hongbing Zhang,et al.  A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. , 2002, Human molecular genetics.

[54]  C. Rommel,et al.  Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.

[55]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[56]  J. Beckmann,et al.  Calpain 3 mRNA expression in mice after denervation and during muscle regeneration. , 2001, American journal of physiology. Cell physiology.

[57]  Antonio Musarò,et al.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.

[58]  R. Michel,et al.  Calcineurin Is Required for Skeletal Muscle Hypertrophy* , 1999, The Journal of Biological Chemistry.

[59]  R. Snell,et al.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.

[60]  R. Michel,et al.  Coordinated expression of myosin heavy chain isoforms and metabolic enzymes within overloaded rat muscle fibers. , 1997, The American journal of physiology.

[61]  R. Roy,et al.  Biochemical properties of overloaded fast-twitch skeletal muscle. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[62]  D. Tonge Physiological characteristics of re‐innervation of skeletal muscle in the mouse , 1974, The Journal of physiology.

[63]  A. Goldberg Work-induced growth of skeletal muscle in normal and hypophysectomized rats. , 1967, The American journal of physiology.